Man Group
SLDB icon

Man Group’s Solid Biosciences SLDB Stock Holding History

Man Group’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-48,922
Closed -$652K – 2251
2024
Q1 		$652K Buy
+48,922
New +$458K ﹤0.01% 1690

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Man Group's SLDB Position: Q2 2024 in Review

Man Group sold out of Solid Biosciences (SLDB) in Q2 2024, closing a stake of 48,922 shares — an estimated $652K sold.

Man Group first reported a position in SLDB in Q1 2024 and held it in 1 quarter. The position peaked at $652K in Q1 2024. 80 funds tracked by Wall St. Rank hold SLDB as of Q2 2024.

  • Man Group reported no remaining Solid Biosciences position as of Q2 2024 after selling out during the quarter.
  • Man Group sold 48,922 Solid Biosciences shares in Q2 2024, an estimated $652K.
  • Man Group first reported a position in Solid Biosciences in Q1 2024 and held it in 1 quarter.
  • Man Group's Solid Biosciences position peaked at $652K in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2024.

Based on Man Group's 13F filing for Q2 2024, filed 14 Aug 2024.